Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 13 Ovarian Neoplasms 5 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Brain Neoplasms 3 Vaginal Neoplasms 2 Thyroid Neoplasms 2 Testicular Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Ovarian Epithelial 2 Adrenal Gland Neoplasms 2 Uterine Neoplasms 1 Thymus Neoplasms 1 Solitary Fibrous Tumors 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Penile Neoplasms 1 Paraganglioma 1

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cytoreductive Surgery × Fluorodeoxyglucose F18 × Gynecologic × Clear all

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡